These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38267841)

  • 1. Mitochondrial disturbance related to increased caspase-1 of CD4
    Yu F; Ma C; Jin X; Zhao H; Xiao J; Li L; Song S; Xie X; Yang S; Tang Y; Wang L; Zhang F
    BMC Infect Dis; 2024 Jan; 24(1):129. PubMed ID: 38267841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroptosis associated with immune reconstruction failure in HIV-1- infected patients receiving antiretroviral therapy: a cross-sectional study.
    Lao X; Mei X; Zou J; Xiao Q; Ning Q; Xu X; Zhang C; Ji L; Deng S; Lu B; Chen M
    BMC Infect Dis; 2022 Nov; 22(1):867. PubMed ID: 36411423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
    Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
    Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.
    Zhang C; Song JW; Huang HH; Fan X; Huang L; Deng JN; Tu B; Wang K; Li J; Zhou MJ; Yang CX; Zhao QW; Yang T; Wang LF; Zhang JY; Xu RN; Jiao YM; Shi M; Shao F; Sékaly RP; Wang FS
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4
    Amand M; Adams P; Schober R; Iserentant G; Servais JY; Moutschen M; Seguin-Devaux C
    Elife; 2023 Feb; 12():. PubMed ID: 36800238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-1 Activity in CD4 T Cells Is Downregulated Following Antiretroviral Therapy for HIV-1 Infection.
    Cai R; Liu L; Luo B; Wang J; Shen J; Shen Y; Zhang R; Chen J; Lu H
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):164-171. PubMed ID: 27832707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.
    Doitsh G; Galloway NL; Geng X; Yang Z; Monroe KM; Zepeda O; Hunt PW; Hatano H; Sowinski S; Muñoz-Arias I; Greene WC
    Nature; 2014 Jan; 505(7484):509-14. PubMed ID: 24356306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery.
    Bandera A; Masetti M; Fabbiani M; Biasin M; Muscatello A; Squillace N; Clerici M; Gori A; Trabattoni D
    Front Immunol; 2018; 9():214. PubMed ID: 29483915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.
    Luo X; Herzig E; Doitsh G; Grimmett ZW; Muñoz-Arias I; Greene WC
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation mRNA Sequencing Reveals Pyroptosis-Induced CD4+ T Cell Death in Early Simian Immunodeficiency Virus-Infected Lymphoid Tissues.
    Lu W; Demers AJ; Ma F; Kang G; Yuan Z; Wan Y; Li Y; Xu J; Lewis M; Li Q
    J Virol; 2016 Jan; 90(2):1080-7. PubMed ID: 26559826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced pyroptosis contributes to the loss of MAIT cells in chronic HIV-1 infected patients.
    Xia P; Xing XD; Yang CX; Liao XJ; Liu FH; Huang HH; Zhang C; Song JW; Jiao YM; Shi M; Jiang TJ; Zhou CB; Wang XC; He Q; Zeng QL; Wang FS; Zhang JY
    Mil Med Res; 2022 May; 9(1):24. PubMed ID: 35619176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in pyroptosis of recent thymic emigrants CD4+ T Lymphocytes in ART-treated HIV-positive patients are influenced by sex.
    Andrade-Santos JL; Carvalho-Silva WHV; Souto FO; Crovella S; Guimarães RL
    Immunogenetics; 2021 Aug; 73(4):349-353. PubMed ID: 33449124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cell free mitochondrial DNA and caspase-1 expression with disease severity and ARTs efficacy in HIV infection.
    Ali Z; Waseem S; Shahzadi I; Bukhari S; Anis RA; Ahmed I; Anees M
    Mol Biol Rep; 2021 Apr; 48(4):3327-3336. PubMed ID: 33886057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction.
    Younes SA; Talla A; Pereira Ribeiro S; Saidakova EV; Korolevskaya LB; Shmagel KV; Shive CL; Freeman ML; Panigrahi S; Zweig S; Balderas R; Margolis L; Douek DC; Anthony DD; Pandiyan P; Cameron M; Sieg SF; Calabrese LH; Rodriguez B; Lederman MM
    J Clin Invest; 2018 Nov; 128(11):5083-5094. PubMed ID: 30320604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.
    Shive CL; Mudd JC; Funderburg NT; Sieg SF; Kyi B; Bazdar DA; Mangioni D; Gori A; Jacobson JM; Brooks AD; Hardacre J; Ammori J; Estes JD; Schacker TW; Rodriguez B; Lederman MM
    J Infect Dis; 2014 Aug; 210(4):619-29. PubMed ID: 24585897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.